RxDoctor Payments Data

Michael Curtin, MD

Orthopaedic Surgery · Boise, IDNPI 1447206065

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.8%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. UOC USA Inc accounts for 61.9% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2021 at $13,824 and has fallen 81.4% since, to $2,566 in 2025.

$32,885in general payments, 2019–2025

Across 95 payments — averaging $346.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UOC USA Inc$20K
  • Arthrex$7K
  • Steelhead Surgical Inc$2K
  • Musculoskeletal Transplant Foundation Inc.$1K
  • Sawtooth Surgical Solutions Inc$1K
  • Stryker$951
  • plus $561 from 8 others

What the payments were for

  • Consulting fees$17,05052%
  • Speaking & faculty fees$4,00012%
  • Travel & lodging$6,13919%
  • Food & beverage$3,29610%
  • Education$2,4007%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,885 in reported general payments places this provider in the 85th percentile of 139 orthopaedic surgery providers in Idaho.

See all orthopaedic surgery providers in Idaho

Medicare billing

Part B allowed, 2024
$71,241
Medicare patients
140
Services billed
293

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron71$674
Doxycycline Hyclate38$525
Celecoxib15$450
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen32$307
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen33$197
Oxycodone Hcl33$118
Tramadol Hcl22$85
Amoxicillin59$85

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Boise

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →